Cost-Utility Analysis Of Abiraterone Versus Enzalutamide In The Treatment Of Metastatic Castration-Resistant Prostate Cancer After Failure Of Androgen Deprivation Therapy
AuthID
P-00R-G10
P-00R-G10
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service